Mackin James P

Mackin James P, President & CEO of AORT (Artivion, Inc.), has demonstrated a consistent pattern of selling activity in the company’s stock over the past two years, with no recent purchases recorded. According to SEC Form 4 filings, Mackin has executed 34 transactions totaling $13.9 million in sales against $4.4 million in buys—a nearly 3:1 sell-to-buy ratio. The selling has been particularly concentrated in recent months, with 17 disposals since late 2024, including multiple high-value transactions in early 2026. Notable sales include a $675,692 disposition on March 3, 2026, preceded by a $566,989 sale the prior day, and a $787,920 transaction on February 23, 2026. Earlier activity in December 2025 saw two sales exceeding $1.4 million each, alongside derivative transactions marked as "M" (merger or acquisition-related). The transactions suggest a sustained reduction in Mackin’s position, with sales occurring at regular intervals rather than as isolated events. While some filings include awards (coded "A") with no reported value—likely representing equity grants—the overall trend points to a net decrease in holdings. The absence of buys since at least 2024, combined with the frequency and scale of disposals, indicates a clear directional bias toward divestment. All activity is confined to AORT, reflecting Mackin’s exclusive focus on his executive role at Artivion. The sales, often clustered around quarterly periods, may align with corporate disclosure timelines, though the filings provide no explicit rationale for the transactions.